These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hepatitis C and kidney transplant: The eradication time of the virus has arrived. Esforzado N; Morales JM Nefrologia (Engl Ed); 2019; 39(5):458-472. PubMed ID: 30905391 [TBL] [Abstract][Full Text] [Related]
23. Clinical trials: Treatment of HCV-infected patients with advanced kidney disease. Ladino M; Roth D Nat Rev Nephrol; 2018 Jan; 14(1):6-8. PubMed ID: 29176656 [No Abstract] [Full Text] [Related]
24. Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial. Durand CM; Bowring MG; Brown DM; Chattergoon MA; Massaccesi G; Bair N; Wesson R; Reyad A; Naqvi FF; Ostrander D; Sugarman J; Segev DL; Sulkowski M; Desai NM Ann Intern Med; 2018 Apr; 168(8):533-540. PubMed ID: 29507971 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in China. Zhang J; Sun W; Lin J; Tian Y; Ma L; Zhang L; Zhu Y; Qiu W BMC Infect Dis; 2019 Jul; 19(1):645. PubMed ID: 31324230 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline. Terrault NA Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896 [No Abstract] [Full Text] [Related]
28. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs. Naggie S; Muir AJ Annu Rev Med; 2017 Jan; 68():345-358. PubMed ID: 27686017 [TBL] [Abstract][Full Text] [Related]
30. Management of hepatitis C infection among patients with renal failure. Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis C and Treatment in Patients with Chronic Kidney Disease. Jalota A; Lindner BK; Thomas B; Lerma EV Dis Mon; 2021 Feb; 67(2):101017. PubMed ID: 32553421 [TBL] [Abstract][Full Text] [Related]
32. Direct-acting agents for hepatitis C virus before and after liver transplantation. Sugawara Y; Hibi T Biosci Trends; 2018 Jan; 11(6):606-611. PubMed ID: 29238003 [TBL] [Abstract][Full Text] [Related]
33. Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era. Devresse A; Delire B; Lazarus JV; Kabamba B; De Meyer M; Mourad M; Buemi A; Darius T; Cambier JF; Goffin E; Jadoul M; Kanaan N Transplant Proc; 2020 Apr; 52(3):815-822. PubMed ID: 32143864 [TBL] [Abstract][Full Text] [Related]
34. [Hepatitis C infections in dialyzed patients]. Podlasin RB Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565 [TBL] [Abstract][Full Text] [Related]
35. Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective study. Gendia M; Lampertico P; Alfieri CM; D'Ambrosio R; Gandolfo MT; Campise MR; Fabrizi F; Messa P Transpl Int; 2019 May; 32(5):493-501. PubMed ID: 30580473 [TBL] [Abstract][Full Text] [Related]
36. The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era. Radhakrishnan RC; Gopal B; Zachariah UG; Abraham P; Mohapatra A; Valson AT; Alexander S; Jacob S; Tulsidas KS; David VG; Varughese S Saudi J Kidney Dis Transpl; 2018; 29(5):1092-1099. PubMed ID: 30381505 [TBL] [Abstract][Full Text] [Related]
37. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus. Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients. Kadatz M; Klarenbach S; Gill J; Gill JS Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402 [TBL] [Abstract][Full Text] [Related]
39. Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index? Goldfarb DA J Urol; 2020 Dec; 204(6):1369. PubMed ID: 32955983 [No Abstract] [Full Text] [Related]
40. Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up. Wettersten N; Tran H; Mekeel K; Pretorius V; Adler E; Aslam S Transpl Infect Dis; 2019 Feb; 21(1):e13002. PubMed ID: 30222242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]